Navigation Links
Somanetics Corporation to Release Fourth Quarter and Fiscal 2008 Financial Results and Host Conference Call January 21, 2009
Date:1/6/2009

TROY, Mich., Jan. 6 /PRNewswire-FirstCall/ -- Somanetics Corporation (Nasdaq: SMTS) will release its financial results for the fourth quarter and fiscal year ended November 30, 2008 before the opening of the market on Wednesday, January 21, 2009. In conjunction with its financial results, the Company will host a conference call that will be webcast live at 10:00 a.m. (ET) the same day.

On the conference call, Bruce Barrett, Somanetics' president and chief executive officer, and Bill Iacona, chief financial officer, will review Somanetics' financial results and provide a business outlook for fiscal 2009.

To listen to the webcast, visit the Investor Center page of Somanetics' website at www.somanetics.com 15 minutes prior to the event's broadcast and click on the "2008 Year-End Conference Call" link. Interested parties unable to listen to the live call may access the archived version of the call on the Investor Center page of Somanetics' website for one year after the call. Windows Media Player is required for access to the webcast and is available for downloading free of charge on the webcast page.

About Somanetics

Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and markets the INVOS(R) Cerebral/Somatic Oximeter, a non-invasive patient monitoring system that continuously measures changes in the blood oxygen levels in the brain and elsewhere in the body in patients with or at risk for restricted blood flow. Surgeons, anesthesiologists and other medical professionals can use the information provided by the INVOS System, in conjunction with other available information, to identify oxygen imbalances in tissues beneath the sensor and take necessary corrective action, potentially improving patient outcomes and reducing the costs of care. The INVOS System has a nearly 11-year market track record supported by more than 600 clinical references, and is used at nearly 700 U.S. hospitals. Somanetics supports its customers through a direct U.S. sales force and clinical education team. Covidien markets INVOS System products in Europe, Canada, the Middle East and South Africa and Edwards Lifesciences represents INVOS System products in Japan. For more information visit www.somanetics.com.


'/>"/>
SOURCE Somanetics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Somanetics Corporation to Present at Rodman & Renshaw Annual Global Investment Conference
2. Somanetics Announces Share Repurchase Program Increased By $15 Million
3. Somanetics Receives 510(k) Clearance From the FDA to Expand INVOS System Labeling
4. Somanetics Corporation to Present at Citigroup 2008 Healthcare Conference
5. Somanetics Announces Share Repurchase Program Increased by $15 Million
6. Somanetics Announces Share Repurchase Program
7. Somanetics Reports Financial Results for the First Quarter of Fiscal 2008
8. Somanetics Corporation to Release First Quarter 2008 Financial Results and Host Conference Call March 18, 2008
9. Somanetics Corporation to Release Fourth Quarter and Fiscal 2007 Financial Results and Host Conference Call January 23, 2008
10. Somanetics Corporation to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
11. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 2016 , ... Healthcare is in flux. The GOP wants ... mass media launching of story movements to highlight what's most unfair about healthcare. ... such a movement can generate the network power to improve healthcare policies in ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... that serve communities in and around the greater Phoenix metropolitan region, is announcing ... Connection. , The mission of the Homeless Youth Connection is to promote community ...
(Date:12/7/2016)... PA (PRWEB) , ... December 07, 2016 , ... ... with the announcement that it is one of the early adopters completing EU-U.S. Privacy ... Framework is designed to provide companies on both sides of the Atlantic with a ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... wrinkles and deep lines by smoothing and tightening the skin of the face ... there to address facial aging with very little downtime, Silhouette Instalift is a ...
(Date:12/7/2016)... ... December 07, 2016 , ... It is vital for any lab to secure ... data. The team at Beckman Coulter has designed Kaluza, templates with advanced analytical tools ... need to operate in a GLP (Good Laboratory Practice) fashion. , With features designed ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Eli Lilly and ... the neoMONARCH study of abemaciclib, a cyclin-dependent kinase (CDK) ... of reducing expression of Ki67, a biomarker of cell ... the Phase 2 trial presented during the official press ... (SABCS) evaluated abemaciclib, both alone or in combination with ...
(Date:12/7/2016)... Global Cervical Dysplasia Market: Scope and ... dysplasia market analyzes the current and future prospects ... executive summary, including a market snapshot that provides ... The research is a combination of primary and ... our research efforts along with information collected from ...
(Date:12/7/2016)... REPORT OBJECTIVES The report ... intelligence on a market segment, based on geography. ... in the report. The primary objectives of this ... intelligence through detailed segmentation, 2) market size and ... developments, market situation, trends, 3) detailed analysis of ...
Breaking Medicine Technology: